Feng Y, Cao S, Shi Y, Sun A, Flanagan M, Leverenz J
Alzheimers Dement. 2025; 21(2):e14595.
PMID: 39985481
PMC: 11846481.
DOI: 10.1002/alz.14595.
Peng L, Zhang Z, Li Q, Song Z, Yan C, Ling H
Heliyon. 2024; 10(20):e39217.
PMID: 39629139
PMC: 11612466.
DOI: 10.1016/j.heliyon.2024.e39217.
Alhenaky A, Alhazmi S, Alamri S, Alkhatabi H, Alharthi A, Alsaleem M
J Clin Med. 2024; 13(22).
PMID: 39598105
PMC: 11594708.
DOI: 10.3390/jcm13226960.
Liu W, Rao X, Sun W, Chen X, Yu L, Zhang J
Mol Cell Biochem. 2024; .
PMID: 39567427
DOI: 10.1007/s11010-024-05164-0.
Jia F, Han W, Gao S, Huang J, Zhao W, Lu Z
Front Mol Biosci. 2024; 11:1478611.
PMID: 39513039
PMC: 11540791.
DOI: 10.3389/fmolb.2024.1478611.
Formaldehyde initiates memory and motor impairments under weightlessness condition.
Mei T, Chen Y, Gao Y, Zhao H, Lyu X, Lin J
NPJ Microgravity. 2024; 10(1):100.
PMID: 39468074
PMC: 11519943.
DOI: 10.1038/s41526-024-00441-0.
NACC2, a molecular effector of miR-132 regulation at the interface between adult neurogenesis and Alzheimer's disease.
Penning A, Snoeck S, Garritsen O, Tosoni G, Hof A, de Boer F
Sci Rep. 2024; 14(1):21163.
PMID: 39256511
PMC: 11387632.
DOI: 10.1038/s41598-024-72096-6.
Beneficial effects of miR-132/212 deficiency in the zQ175 mouse model of Huntington's disease.
Nateghi B, Keraudren R, Boulay G, Bazin M, Goupil C, Canet G
Front Neurosci. 2024; 18:1421680.
PMID: 39170678
PMC: 11337869.
DOI: 10.3389/fnins.2024.1421680.
Downregulation of hsa-miR-132 and hsa-miR-129: non-coding RNA molecular signatures of Alzheimer's disease.
Nagaraj S, Quintanilla-Sanchez C, Ando K, Lopez-Gutierrez L, Doeraene E, Kosa A
Front Mol Neurosci. 2024; 17:1423340.
PMID: 38984196
PMC: 11231994.
DOI: 10.3389/fnmol.2024.1423340.
MicroRNA biomarkers as next-generation diagnostic tools for neurodegenerative diseases: a comprehensive review.
Azam H, Rossling R, Geithe C, Khan M, Dinter F, Hanack K
Front Mol Neurosci. 2024; 17:1386735.
PMID: 38883980
PMC: 11177777.
DOI: 10.3389/fnmol.2024.1386735.
Noncoding RNAs in Alzheimer's Disease: Overview of Functional and Therapeutic Significance.
Adiga D, Eswaran S, Srinath S, Khan N, Kumar D, Kabekkodu S
Curr Top Med Chem. 2024; 24(19):1615-1634.
PMID: 38616763
DOI: 10.2174/0115680266293212240405042540.
MOCAT: multi-omics integration with auxiliary classifiers enhanced autoencoder.
Yao X, Jiang X, Luo H, Liang H, Ye X, Wei Y
BioData Min. 2024; 17(1):9.
PMID: 38444019
PMC: 10916109.
DOI: 10.1186/s13040-024-00360-6.
Exercise mimetics: a novel strategy to combat neuroinflammation and Alzheimer's disease.
Zhao R
J Neuroinflammation. 2024; 21(1):40.
PMID: 38308368
PMC: 10837901.
DOI: 10.1186/s12974-024-03031-9.
Large-scale gene expression changes in APP/PSEN1 and GFAP mutation models exhibit high congruence with Alzheimer's disease.
Gammie S, Messing A, Hill M, Kelm-Nelson C, Hagemann T
PLoS One. 2024; 19(1):e0291995.
PMID: 38236817
PMC: 10796008.
DOI: 10.1371/journal.pone.0291995.
Potential Implications of miRNAs in the Pathogenesis, Diagnosis, and Therapeutics of Alzheimer's Disease.
Wang L, Shui X, Diao Y, Chen D, Zhou Y, Lee T
Int J Mol Sci. 2023; 24(22).
PMID: 38003448
PMC: 10671222.
DOI: 10.3390/ijms242216259.
Lowering Hippocampal miR-29a Expression Slows Cognitive Decline and Reduces Beta-Amyloid Deposition in 5×FAD Mice.
Mei Z, Liu J, Schroeder J, Weinshenker D, Duong D, Seyfried N
Mol Neurobiol. 2023; 61(6):3343-3356.
PMID: 37989983
PMC: 11087195.
DOI: 10.1007/s12035-023-03791-0.
Small molecule regulators of microRNAs identified by high-throughput screen coupled with high-throughput sequencing.
Nguyen L, Wei Z, Silva M, Barberan-Soler S, Zhang J, Rabinovsky R
Nat Commun. 2023; 14(1):7575.
PMID: 37989753
PMC: 10663445.
DOI: 10.1038/s41467-023-43293-0.
Alzheimer's Disease-Related Epigenetic Changes: Novel Therapeutic Targets.
Paniri A, Hosseini M, Akhavan-Niaki H
Mol Neurobiol. 2023; 61(3):1282-1317.
PMID: 37700216
DOI: 10.1007/s12035-023-03626-y.
A state-of-the-art review on miRNA in prevention and treatment of Alzheimers disease.
Guo X
Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023; 52(4):485-498.
PMID: 37643982
PMC: 10495246.
DOI: 10.3724/zdxbyxb-2023-0324.
Discerning the Prospects of miRNAs as a Multi-Target Therapeutic and Diagnostic for Alzheimer's Disease.
Bhatnagar D, Ladhe S, Kumar D
Mol Neurobiol. 2023; 60(10):5954-5974.
PMID: 37386272
DOI: 10.1007/s12035-023-03446-0.